1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Ustekinumab for moderately to severely active Crohn’s disease after previous treatment

Technology appraisal guidance [TA456] Published date: 12 July 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Documents

A list of downloadable documents created during development.

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 439.97 KB 27 April 2017  
  • Committee papers PDF 19.14 MB 27 April 2017  
  • Public committee slides PDF 460.3 KB 27 April 2017  
  • Public committee slides PDF 458.17 KB 27 April 2017  
  • Final appraisal determination document Equality Impact Assessment PDF 223.17 KB 27 April 2017  
  • Final appraisal determination document 2nd Final appraisal determination PDF 444.25 KB 16 June 2017  

Invitation to participate

  • Final scope PDF 171.41 KB 06 October 2016  
  • Final matrix PDF 152.83 KB 06 October 2016  
  • Draft scope and provisional matrix comments table (post-referral) PDF 214.28 KB 06 October 2016  
  • Equality impact assessment (Scoping) PDF 120.96 KB 06 October 2016